Clinical Trial: Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot be Removed by Surgery or Transplant

Share this article:
Clinical Trial: Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot be Removed by Surgery or Transplant

Sponsor and Collaborators

Case Comprehensive Cancer Center

Principal Investigator
Juan Sanabria Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

ClinicalTrials.gov Identifier
NCT01194206
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Liver Cancer Clinical Trials

Clinical Trial: Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating ...

Clinical Trial focusing on advanced liver cancer treatment. Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Clinical Trials: Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That ...

Clinical trial focusing on chemoembolization versus radioembolization in liver cancer patients. Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Clinical Trial: Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating ...

Clinical trial focusing on transarterial chemoembolization. Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer